Skip to main content
. 2008 Jun 18;82(17):8431–8441. doi: 10.1128/JVI.00551-08

FIG. 3.

FIG. 3.

NS-gEnull vaccination protects against disease and reduces the recovery of latent virus from DRG after flank challenge with HSV-1(KOS) at 105 PFU. (A and B) Mice were monitored for inoculation site disease (P = 0.03) and zosteriform disease (P = 0.04 on day 5; P < 0.001 on days 6 and 7). The data points are means ± SEMs. (C) DRG explant cocultures were performed 28 days after challenge (P < 0.001). There were 10 mice in each group.